UK Implements Use of Adjuvanted Trivalent Influenza Vaccine for Adults Over 65

As influenza season approaches, health officials in the UK have announced new influenza vaccination recommendations for individuals >65. In August of 2017, the Medicines and Healthcare Products Regulatory Agency approved FLUAD, an adjuvanted trivalent vaccine (aTIV) designed to better protect adults >65 years. This flu season will be the first season the vaccination will be used in the UK